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ABSTRACT
Objective. The study objective is to analyze influenza vaccination status by demographic
factors, perceived vaccine efficacy, social influence, herd immunity, vaccine cost, health
insurance status, and barriers to influenza vaccination among adults 18 years and older
in the United States.
Background. Influenza vaccination coverage among adults 18 years and older was 41%
during 2010–2011 and has increased and plateaued at 43% during 2016–2017. This
is below the target of 70% influenza vaccination coverage among adults, which is an
objective of the Healthy People 2020 initiative.
Methods. We conducted a survey of a nationally representative sample of adults 18
years and older in the United States on factors affecting influenza vaccination. We
conducted bivariate analysis using Rao-Scott chi-square test and multivariate analysis
usingweightedmultinomial logistic regression of this survey data to determine the effect
of demographics, perceived vaccine efficacy, social influence, herd immunity, vaccine
cost, health insurance, and barriers associated with influenza vaccination uptake among
adults in the United States.
Results. Influenza vaccination rates are relatively high among adults in older age groups
(73.3% among 75+ year old), adults with education levels of bachelor’s degree or higher
(45.1%), non-Hispanic Whites (41.8%), adults with higher incomes (52.8% among
adults with income of over $150,000), partnered adults (43.2%), non-working adults
(46.2%), and adults with internet access (39.9%). Influenza vaccine is taken every year
by 76% of adults who perceive that the vaccine is very effective, 64.2% of adults who are
socially influenced by others, and 41.8% of adults with health insurance, while 72.3%
of adults without health insurance never get vaccinated. Facilitators for adults getting
vaccinated every year in comparison to only some years include older age, perception of
high vaccine effectiveness, higher income and no out-of-pocket payments. Barriers for
adults never getting vaccinated in comparison to only some years include lack of health
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insurance, disliking of shots, perception of low vaccine effectiveness, low perception of
risk for influenza infection, and perception of risky side effects.
Conclusion. Influenza vaccination rates among adults in the United States can be
improved towards the Healthy People 2020 target of 70% by increasing awareness
of the safety, efficacy and need for influenza vaccination, leveraging the practices and
principles of commercial and social marketing to improve vaccine trust, confidence and
acceptance, and lowering out-of-pocket expenses and covering influenza vaccination
costs through health insurance.
Subjects Epidemiology, Infectious Diseases, Public Health, Statistics
Keywords Influenza, Survey analysis, Adult vaccination, United States, Facilitators, Barriers
INTRODUCTION
Influenza has caused between 9.2 million and 35.6 million illnesses, between 140,000
and 710,000 hospitalizations, and between 12,000 and 56,000 deaths annually in the
United States since 2010 (CDC, 2017). Influenza vaccination is an effective public health
intervention to lower the morbidity and mortality burden from influenza. The Advisory
Committee on Immunization Practices of the Centers for Disease Control and Prevention
recommends influenza vaccination for everyone 6 months or older (Grohskopf et al., 2017).
Influenza vaccination coverage among children (6 months to 17 years) was 59.0% and
among adults (18 years and older) was 43.3% during the 2016–2017 influenza season
(CDC, 2018). While the influenza vaccination coverage among adults 18 years and older
has increased from 40.5% during 2010–2011 to 43.3% during 2016–2017, it has plateaued
and is below the target of 70% influenza vaccination coverage among adults as part of the
Healthy People 2020 initiative (ODPHP, 2018).
Knowledge, attitudes, and beliefs affecting influenza vaccination
Prior studies have identified demographic factors, and knowledge, attitudes and beliefs
affecting influenza vaccination, especially among elderly Americans. Demographic factors
include age (Van Essen, Kuyvenhoven & De Melker, 1997; Petersen et al., 1999) and race
(CDC, 2018). Facilitators include the awareness of the safety, efficacy and need for
influenza vaccination (CDC, 1999), physician recommendations (CDC, 1999; Zimmerman
et al., 2003), fear of contracting influenza without influenza vaccination (Zimmerman
et al., 2003), social forces influencing vaccination behavior (Tabbarah et al., 2005), and
disagreement with the view that the vaccine is detrimental (Tabbarah et al., 2005), while
barriers include fear of side effects (CDC, 1999), efficacy concerns (Fiebach & Viscoli, 1991;
CDC, 1999), and fear of vaccines causing influenza (Nichol, Lofgren & Gapinski, 1992;CDC,
1999; Zimmerman et al., 2003).
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Study objective
The study objective is to analyze influenza vaccination status by demographic factors,
perceived vaccine efficacy, social influence, herd immunity, vaccine cost, health insurance
status, and barriers to influenza vaccination among adults 18 years and older in the United
States.
Public health significance
The public health significance of this study is to understand and analyze the demographics,
perceptions, and socioeconomic factors affecting influenza vaccination among adults in
the United States, and provide evidence to improve influenza vaccination rates among the
adults toward the Healthy People 2020 target of 70% (ODPHP, 2018).
METHODS
We conducted an online survey in 2016 of a nationally representative sample of the general
population of adults 18 years and over in the United States. Data was collected from 2,150
respondents in the survey which was administered by the Gfk Group using a sample from
KnowledgePanel, a probabilistic-based web panel designed to be representative of the
United States population. The Institutional Review Board at Virginia Tech granted ethical
approval for this study (IRB # 14-712), and the survey was conducted by the Gfk Group
with the consent of the participants.
Survey questionnaire
Survey questions were based on the health behavioral framework of the health belief
model (Rosenstock, 1974; Coe et al., 2012; Santos et al., 2017) and the socioecological
model (McLeroy et al., 1988; Kumar et al., 2012; Niyibizi, Schamel & Frew, 2016). The
health belief model illustrates that health-related behavior, such as getting influenza
vaccine, is influenced by perceived susceptibility, perceived severity, perceived benefits,
perceived barriers, cues to action, and self-efficacy. The socioecological model explains that
health-related behavior of individuals is influenced by their perceptions, social influences,
and structural factors such as access to health care and insurance. Specifically, our survey
questions were focused on understanding perceived vaccine efficacy, social influences
and herd immunity, vaccine cost and health insurance, and barriers affecting influenza
vaccination in adults, as illustrated in Table 1.
Bivariate analysis
We analyzed vaccination status by respondent’s gender, age, education, ethnicity, income,
marital status, metro status, region, work status, and internet access using Rao-Scott’s
chi-square test (Table 2). We also analyzed vaccination status by perceived vaccine efficacy,
social influence and herd immunity, vaccine cost and health insurance, and barriers to
vaccination using Rao-Scott’s chi-square test (Table 3).
Marital status refers to partnered adults (married or living together) and single adults
(never married, separated, divorced, or widowed). Metro status refers to metropolitan
areas with a relatively high population density at its centre with proximal economic ties
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Table 1 Influenza vaccination survey. Factors of vaccination status, perceived efficacy, social influence, herd immunity, vaccine cost, health insur-
ance, and barriers to vaccination were included in the survey questionnaire.
Factors Survey questions Response choices
Vaccination status Do you get an influenza vaccine? 1. Yes, every year
2. Yes, some years
3. No, never
Perceived efficacy How effective do you think the influenza vaccine is in
protecting people from becoming sick with influenza?
1. Very effective
2. Somewhat effective
3. Not effective
4. It varies from season to season
5. Don’t know
Social influence Are you more likely to get a vaccine if others around you get
a vaccine?
1. Yes, more likely
2. No, less likely
3. No, no effect
Are you more likely to get a vaccine if others around you do
not get a vaccine?
1. Yes, more likely
2. No, less likely
3. No, no effect
Herd immunity Do you get a vaccine to protect yourself, protect others, or
protect yourself and others?
1. Protect myself
2. Protect others
3. Protect myself and others
Vaccine cost How much do you pay to get an influenza vaccine? 1. $0
2. Less than $30
3. $30 to $60
4. More than 60$
5. Don’t know
Health insurance Do you have health insurance? 1. Yes
2. No
Are influenza vaccines covered by your health insurance? 1. Yes, the full cost is paid
2. Yes, but only part of the cost is paid
3. No
4. Don’t know
Barriers What are the reasons you would not get an influenza
vaccine? (check all that apply)
1. The vaccine costs too much
2. The vaccine is not very effective in preventing influenza
3. I am not likely to get influenza
4. Do not know where to get vaccine
5. The side effects of the vaccine are too risky
6. I am allergic to some of the ingredients in the vaccine
7. I do not like shots
8. I just don’t get around to doing it
9. I have to travel too far to get vaccine
10. Other, please specify
throughout the area. Working status refers to working as a paid employee and working
as self-employed; categories of non-working status includes temporary layoff, looking for
work, retired, disabled, and other. Region refers to Midwest, Northeast, South, and West
regions of the US. Internet access refers to access to the internet and is not specific to access
at work or home nor is based on the usage.
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Table 2 Demographic characteristics of survey respondents. Respondent characteristics by gender, age, education, ethnicity, income, marital sta-
tus, metro status, region, work status, and internet access among adults 18 years and older in the United States.
Do you get an influenza vaccine? (n= 2150)
Respondent characteristics Yes, every year
(n= 908)
Yes, some years
(n= 423)
No, never
(n= 819)
p-value
n % n % n %
Gender
Female 460 39.4% 227 21.8% 408 38.8% 0.4
Male 448 38.6% 196 19.8% 411 41.6%
Age (years)
18–24 45 25.5% 49 29.2% 78 45.3% <0.001
25–34 73 24.0% 82 28.4% 134 47.6%
35–44 102 30.9% 75 23.2% 147 45.9%
45–54 138 35.5% 86 22.8% 160 41.7%
55–64 238 47.8% 78 14.6% 181 37.6%
65–74 201 58.3% 45 13.6% 93 28.1%
75+ 111 73.3% 8 6.2% 26 20.5%
Education level
Less than high school 60 34.7% 27 17.6% 73 47.7% <0.001
High school 271 40.9% 79 13.6% 279 45.5%
Some college 218 32.3% 147 26.6% 239 41.1%
Bachelor’s degree or higher 359 45.1% 170 24.0% 228 30.9%
Ethnicity
White, Non-Hispanic 696 41.8% 293 19.8% 567 38.5% 0.01
Black, Non-Hispanic 69 33.2% 37 18.6% 88 48.2%
Hispanic 80 32.8% 54 24.5% 94 42.8%
Other, Non-Hispanic 36 37.9% 28 28.3% 29 33.8%
2+ Races, Non-Hispanic 27 31.5% 11 14.8% 41 53.7%
Income
under $10k 24 27.2% 15 17.0% 50 55.8% <0.001
$10k to $25k 83 30.7% 36 16.7% 118 52.6%
$25k to $50k 178 37.6% 81 19.2% 183 43.2%
$50k to $75k 168 37.9% 78 21.8% 158 40.3%
$75k to $100k 131 37.9% 74 24.3% 106 37.9%
$100k to $150k 213 44.3% 99 23.3% 146 32.4%
over $150k 111 52.8% 40 19.8% 58 27.3%
Marital status
Single 302 33.7% 160 19.9% 374 46.4% <0.001
Partnered 606 43.2% 263 21.6% 445 35.3%
Metro status
Metro 772 38.9% 376 21.9% 682 39.2% 0.02
Non-metro 136 39.9% 47 14.9% 137 45.2%
(continued on next page)
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Table 2 (continued)
Do you get an influenza vaccine? (n= 2150)
Respondent characteristics Yes, every year
(n= 908)
Yes, some years
(n= 423)
No, never
(n= 819)
p-value
n % n % n %
Region
Midwest 203 39.0% 91 19.9% 182 41.1% 0.002
Northeast 174 40.3% 81 19.8% 164 39.9%
South 330 39.5% 127 17.4% 303 43.1%
West 201 37.2% 124 28.1% 170 34.6%
Work status
Not working 454 46.2% 142 17.5% 296 36.2% <0.001
Working 454 34.1% 281 23.1% 523 42.8%
Internet status
No 130 35.9% 49 15.1% 172 49.0% <0.001
Yes 778 39.9% 374 22.4% 647 37.7%
Multivariate analysis
Statistically significant variables (p-value ≤ 0.05) from the bivariate analysis were included
in the forward selection procedure for multivariate analysis using weighted multinomial
logistic regression.We analyzed respondent demographics (age, education, income, region,
work status), perceived efficacy, social influence, cost and health insurance associated with
getting the influenza vaccine using weighted multinomial logistic regression (Table 4). We
compared the responses of adults who get the influenza vaccine every year to those who
get the influenza vaccine some years. We analyzed demographics (age, education, income,
region, work status), perceived efficacy, health insurance, and barriers associated with not
getting the influenza vaccine using weighted multinomial logistic regression (Table 5). We
compared the responses of adults who never get the influenza vaccine to those who get the
influenza vaccine some years. All statistical analysis was performed using the R software
for statistical computing (R Core Team, 2018).
RESULTS
Influenza vaccination by demographics
We analyzed influenza vaccination status of adults by gender, age, education, ethnicity,
income, marital status, metro status, region, work status, and internet access using Rao-
Scott’s chi-square test, as illustrated in Table 2. Vaccination status refers to adults being
vaccinated every year, some years, or never with the influenza vaccine. We observed an
association between vaccination status and the demographic variables of age, education,
ethnicity, income, marital status, work status, and internet access.
A total of 73.3% of adults over 75 get vaccinated every year compared to only 25.5%
of 18–24 year old adults. A total of 45.1% of adults with a bachelor’s degree or higher
get vaccinated every year compared with 34.7% of adults with less than a high school
education. A total of 41.8% of White, non-Hispanic adults get vaccinated every year, while
53.7% of non-Hispanic 2+ races’ adults and 48.2% of non-Hispanic Black adults never get
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Table 3 Perceived efficacy, social influence, herd immunity, vaccine cost, health insurance, and barriers by vaccination status among adults 18
years and older in the United States.
Do you get an influenza vaccine?
Yes, every year
(n= 908)
Yes, some years
(n= 423)
No, never
(n= 819)
Variable Response n % n % n % p-value Total
(n= 2,150)
Perceived efficacy
Very effective 304 76.0% 45 14.1% 34 9.9% <0.001 383
Somewhat effective 435 41.6% 240 26.9% 285 31.5% 960
Not effective 141 31.2% 94 21.8% 198 47.0% 433
It varies from season to season 6 4.4% 16 14.2% 120 81.4% 142
How effective do you think the
influenza vaccine is in protecting
people from becoming sick with
influenza?
Don’t know 19 7.8% 27 12.5% 180 79.7% 226
Social influence
Yes, more likely 254 64.2% 127 35.8% – – <0.001 381
No, no effect 620 68.1% 258 31.9% – – 878
Are you more likely to get a
vaccine if others around you get
a vaccine? No, less likely 33 43.1% 37 57.0% – – 70
Yes, more likely 252 78.4% 61 21.6% – – <0.001 313
No, no effect 610 64.6% 294 35.4% – – 904
Are you more likely to get a
vaccine if others around you do
not get a vaccine? No, less likely 37 33.6% 64 66.4% – – 101
Herd immunity
Protect myself 243 60.2% 138 39.8% – – <0.001 381
Protect myself and others 653 68.3% 268 31.8% – – 921
Do you get a vaccine to protect
yourself, protect others, or pro-
tect yourself and others? Protect others 6 26.2% 16 73.8% – – 22
Vaccine cost
$0 723 71.9% 247 28.1% – – <0.001 970
Less than $20 118 51.7% 104 48.3% – – 222
$30 to $60 28 46.5% 26 53.5% – – 54
More than $60 – – – – – – –
How much do you pay to get an
influenza vaccine?
Don’t know 34 35.8% 46 64.2% – – 80
Health insurance
Yes 887 41.8% 396 21.2% 708 37.0% <0.001 1,991
Do you have health insurance?
No 19 11.3% 24 16.4% 110 72.3% 153
Yes, the full cost is paid 731 54.5% 249 20.7% 301 24.8% <0.001 1,281
Yes, but only part 61 36.3% 47 34.6% 44 29.2% 152
No 19 36.3% 13 23.6% 23 40.1% 55
Are influenza vaccines covered
by your health insurance?
Don’t know 75 14.6% 86 18.2% 339 67.2% 500
(continued on next page)
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Table 3 (continued)
Do you get an influenza vaccine?
Yes, every year
(n= 908)
Yes, some years
(n= 423)
No, never
(n= 819)
Variable Response n % n % n % p-value Total
(n= 2,150)
Barriers
1. The vaccine costs too much – – 61 54.0% 49 46.0% <0.001 110
2. The vaccine is not very effective
in preventing influenza
– – 143 43.4% 196 56.6% <0.001 339
3. I am not likely to get influenza – – 75 25.2% 203 74.8% <0.001 278
4. Do not know where to get the
vaccine
– – 14 35.4% 19 62.6% 0.9 33
5. The side effects of the vaccine are
too risky
– – 65 22.2% 219 77.9% <0.001 284
6. I am allergic to some of the
ingredients in the vaccine
– – 23 40.4% 35 59.6% 0.3 58
7. I do not like shots – – 70 26.2% 196 73.8% 0.004 266
8. I just don’t get around to doing it – – 183 48.0% 181 52.0% <0.001 364
What are the reasons you would
not get an influenza vaccine?
9. I have to travel too far to get
vaccine
– – 10 43.3% 16 56.7% 0.3 26
vaccinated. A total of 52.8% of adults earning more than $150,000 get vaccinated every year
compared with 27.2% of adults earning less than $10,000. A total of 43.2% of partnered
adults get vaccinated every year while 46.4% of single adults never get vaccinated. A total
of 46.2% of non-working adults get vaccinated every year compared with 34.1% of the
working adults. A total of 39.9% of adults with internet access get vaccinated every year
compared with 35.9% of adults without internet access.
Similar proportions of adults get vaccinated every year in both metro (38.9%) and
non-metro (39.9%) areas. Regional vaccination status rates were also similar, with a
relatively higher proportion of adults (40.3%) in the Northeast getting vaccinated every
year compared with the lowest proportion of 37.2% in the American West.
Influenza vaccination by perceived efficacy, social influence, herd
immunity, vaccine cost, health insurance, and barriers
We performed bivariate analysis using Rao-Scott’s chi-square test to analyze influenza
vaccination status by perceived efficacy, social influence, herd immunity, vaccine cost, health
insurance, and barriers to vaccination, and observed an association between them as
illustrated in Table 3.
A total of 76% of adults who perceive that the vaccine is very effective get vaccinated
every year compared with 31.2% who perceive that the vaccine is not effective. A total of
64.2% of adults, who are more likely to get influenza vaccination if others around them are
also vaccinated, get vaccinated every year. A total of 78.4% of adults, who are more likely
to get vaccinated if others around them do not get vaccinated, get vaccinated every year. A
total of 68.3% of adults, who get influenza vaccination to protect themselves and others,
also get vaccinated every year.
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Table 4 Demographics, perceived efficacy, social influence, herd immunity, vaccine cost and health insurance associated with getting influenza
vaccine.Demographics (age, education, income, region, work status), perceived efficacy, social influence, herd immunity, vaccine cost and health
insurance associated with getting influenza vaccine among adults 18 years and older in the United States.
Variable ‘‘Yes, every year’’
(versus ‘‘Yes, some years’’)
AOR 95%CI p-value
Age (years) (Referent: 18–24)
25–34 1.05 (0.54, 2.05) 0.89
35–44 1.47 (0.78, 2.77) 0.23
45–54 1.63 (0.89, 2.99) 0.11
55–64 3.43 (1.9, 6.22) <0.001
65–74 4.46 (2.3, 8.65) <0.001
75+ 9.87 (3.96, 24.6) <0.001
Education level (Referent: Less than high school)
High school 1.39 (0.7, 2.76) 0.35
Some college 0.64 (0.33, 1.24) 0.18
Bachelor’s degree or higher 1.07 (0.54, 2.09) 0.85
Income (Referent: Under $10k)
$10k to $25k 1.84 (0.6, 5.66) 0.29
$25k to $50k 2.22 (0.74, 6.6) 0.15
$50k to $75k 2.65 (0.89, 7.9) 0.08
$75k to $100k 2.28 (0.76, 6.88) 0.14
$100k to $150k 2.37 (0.8, 7.04) 0.12
Over $150k 3.59 (1.16, 11.04) 0.03
Region (Referent: Midwest)
Northeast 0.94 (0.59, 1.49) 0.80
South 1.10 (0.73, 1.64) 0.65
West 0.75 (0.49, 1.15) 0.19
Work status (Referent: Not working)
Working 0.83 (0.59, 1.16) 0.27
Perceived efficacy (Referent: Very effective)
Somewhat effective 0.28 (0.19, 0.42) <0.001
It varies from season to season 0.26 (0.16, 0.42) <0.001
Not effective 0.16 (0.04, 0.6) 0.006
How effective do you think the influenza vaccine is in
protecting people from becoming sick with influenza?
Don’t know 0.15 (0.06, 0.35) <0.001
Social influence (Referent: Yes, more likely)
No, no effect 0.53 (0.37, 0.77) 0.001Are you more likely to get a vaccine if others around
you do not get a vaccine? No, less likely 0.22 (0.12, 0.41) <0.001
(continued on next page)
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Table 4 (continued)
Variable ‘‘Yes, every year’’
(versus ‘‘Yes, some years’’)
AOR 95%CI p-value
Herd immunity (Referent: Protect myself)
Protect myself and others 1.26 (0.92, 1.72) 0.14Do you get a vaccine to protect yourself, protect others,
or protect yourself and others? Protect others 0.38 (0.14, 0.99) 0.05
Vaccine cost (Referent: $0)
Less than $30 0.42 (0.29, 0.6) <0.001
$30 to $60 0.39 (0.2, 0.77) 0.007How much do you pay to get an influenza vaccine?
Don’t know 0.25 (0.13, 0.46) <0.001
Health insurance (Referent: Yes)
Do you have health insurance? No 0.71 (0.32, 1.6) 0.41
A total of 41.8% of adults with health insurance get vaccinated every year compared
with 11.3% of adults without health insurance, while 72.3% of adults without health
insurance never get vaccinated. 71.9% of adults who have null out-of-pocket payment for
the influenza vaccine get vaccinated every year compared to 46.5% of those who pay $30
to $60. Similarly, 54.5% of adults who have the vaccine cost fully covered by their health
insurance get vaccinated every year compared with 36.3% of adults who do not have the
benefit.
A total of 46% of adults who are impacted by high vaccine cost never get vaccinated. A
total of 56.6% of adults who perceive that the vaccine is not very effective in preventing
influenza, 74.8% of adults who perceive that they are unlikely to get influenza, and 77.9%
of adults who perceive that the vaccine side effects are too risky never get vaccinated. A
total of 73.8% of adults who do not like shots and 52% of adults who just do not get around
to getting vaccinated, never get vaccinated.
Demographics, perceived efficacy, social influence, herd immunity,
vaccine cost, and health insurance associated with getting influenza
vaccination
We analyzed demographics (age, education, income, region, work status), perceived efficacy,
social influence, herd immunity, vaccine cost, and health insurance associated with getting
influenza vaccine using weighted multinomial logistic regression, as illustrated in Table 4.
The responses by the adults for getting influenza vaccination every year are compared to
the responses by the adults for getting influenza vaccination some years.
The odds of getting vaccinated every year (versus some years) were significantly higher
for adults 55 years and older compared to younger adults 18–24 years, with an adjusted
odds ratio (AOR) of 9.87 for adults 75 years and older, 4.46 for adults 65–74 years, and 3.43
for adults 55–64 years. Adults with annual income exceeding $150,000 had significantly
higher odds (AOR = 3.59) of getting vaccinated every year (versus some years) compared
to those with incomes below $10,000.
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Table 5 Demographics, perceived efficacy, health insurance, and barriers associated with not getting influenza vaccine.Demographics (age, ed-
ucation, income, region, work status), perceived efficacy, health insurance, and barriers associated with not getting influenza vaccine among adults 18
years and older in the United States.
Variable ‘‘No, never’’
(versus ‘‘Yes, some years’’)
AOR 95%CI p-value
Age (years) (Referent: 18-24)
25–34 0.92 (0.53, 1.62) 0.78
35–44 1.20 (0.70, 2.04) 0.51
45–54 1.09 (0.66, 1.79) 0.74
55–64 1.40 (0.84, 2.35) 0.20
65–74 1.04 (0.57, 1.90) 0.91
75+ 1.62 (0.60, 4.34) 0.34
Education level (Referent: Less than high school)
High school 1.69 (0.92, 3.08) 0.09
Some college 0.64 (0.35, 1.17) 0.15
Bachelor’s degree or higher 0.69 (0.38, 1.28) 0.24
Income (Referent: Under $10k)
$10k to $25k 1.24 (0.53, 2.90) 0.61
$25k to $50k 0.91 (0.43, 1.91) 0.80
$50k to $75k 0.90 (0.41, 1.98) 0.80
$75k to $100k 0.75 (0.34, 1.65) 0.48
$100k to $150k 0.76 (0.35, 1.64) 0.48
Over $150k 0.72 (0.31, 1.66) 0.45
Region (Referent: Midwest)
Northeast 1.05 (0.68, 1.63) 0.83
South 1.27 (0.86, 1.89) 0.23
West 0.62 (0.41, 0.94) 0.02
Work status (Referent: Not working)
Working 1.35 (0.94, 1.93) 0.10
Perceived efficacy (Referent: Very effective)
Somewhat effective 1.86 (1.07, 3.24) 0.03
It varies from season to season 4.05 (2.21, 7.44) <0.001
Not effective 10.36 (4.58, 23.46) <0.001
How effective do you think the influenza
vaccine is in protecting people from be-
coming sick with influenza?
Don’t know 9.01 (4.63, 17.54) <0.001
Health insurance (Referent: Yes)
Do you have health insurance? No 2.04 (1.09, 3.83) 0.03
(continued on next page)
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Table 5 (continued)
Variable ‘‘No, never’’
(versus ‘‘Yes, some years’’)
AOR 95%CI p-value
Barriers (Referent: No)
1. The vaccine costs too much 0.34 (0.21, 0.56) <0.001
2. The vaccine is not very effective in preventing influenza 0.41 (0.29, 0.58) <0.001
3. I am not likely to get influenza 1.95 (1.35, 2.81) <0.001
5. The side effects of the vaccine are too risky 1.98 (1.33, 2.94) <0.001
7. I do not like shots 1.48 (1.01, 2.16) 0.04
What are the reasons you would not get
an influenza vaccine?
8. I just don’t get around to doing it 0.52 (0.38, 0.70) <0.001
Adults who perceive that the influenza vaccine is not effective are 84% less likely (AOR =
0.16) to get vaccinated every year (versus some years) compared to adults who perceive that
it is very effective. Adults who were less likely to get vaccinated if others around them did
not get vaccinated were 78% less likely (AOR = 0.22) to get vaccinated every year (versus
some years), compared to the adults whoweremore likely to get vaccinated if others around
them did not get vaccinated. Adults who get the influenza vaccine to protect others were
62% less likely (AOR= 0.38) to get vaccinated every year (versus some years), compared to
the adults who get vaccinated to protect themselves. The odds of getting vaccinated every
year (versus some years) were significantly lower for adults with out-of-pocket payments
for the influenza vaccine compared to the adults with no out-of-pocket payments, with
an adjusted odds ratio of 0.42 (58% less likely) and 0.39 (61% less likely) for adults with
out-of-pocket payment of less than $30 and $30-$60 respectively.
Demographics, perceived efficacy, health insurance, and barriers
associated with not getting influenza vaccination
We analyzed demographics (age, education, income, region, work status), perceived efficacy,
health insurance, and barriers associated with not getting influenza vaccine using weighted
multinomial logistic regression, as illustrated in Table 5. The responses by the adults for
never getting influenza vaccination are compared to the responses by the adults for getting
influenza vaccination some years.
Adults who perceive that the influenza vaccine is not effective are more likely (AOR
= 10.36) to never getting vaccinated (versus getting vaccinated some years) compared to
adults who perceive that it is very effective. Adults without health insurance are more likely
(AOR= 2.04) to never getting vaccinated (versus getting vaccinated some years) compared
to adults with health insurance.
Adults who perceived low risk of influenza infection were 95% more likely (AOR =
1.95) to never get vaccinated (versus getting vaccinated some years). Adults who perceived
that the vaccine side effects are too risky are 98% more likely (AOR = 1.98) to never get
vaccinated (versus getting vaccinated some years). Adults who do not like shots are 48%
more likely (AOR = 1.48) to never get vaccinated (versus getting vaccinated some years).
Adults who are impacted by high vaccine cost are 66% less likely (AOR= 0.34) to never
get vaccinated (versus getting vaccinated some years). Adults who perceive that the vaccine
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is not very effective in preventing influenza are 59% less likely (AOR = 0.41) to never get
vaccinated (versus getting vaccinated some years). Adults who just do not get around to
getting vaccinated are 48% less likely (AOR= 0.52) to never get vaccinated (versus getting
vaccinated some years). While high cost, perception of low vaccine efficacy, and not getting
around to getting vaccinated are barriers associated with never getting vaccinated, adults
with these barriers are still more likely to get vaccinated some years compared to never
getting vaccinated.
DISCUSSION
Demographics
The proportion of adults getting influenza vaccination every year increases with age, while
the proportion of adults never getting influenza vaccination decreases with age. Adults
with higher education levels (bachelor’s degree or higher) are more likely to get vaccinated
every year, while the proportion of adults who never get vaccinated increases with low
education levels. While a high proportion of non-Hispanic White adults get vaccinated
every year, a large proportion of non-Hispanic Black adults never get vaccinated. Adults
with higher income are more likely to get vaccinated every year, while the proportion of
adults who never get vaccinated increases with lower income. Partnered adults (married,
living together) are more likely to get vaccinated every year, while single adults (never
married, divorced, widowed) are more likely to never get vaccinated. Adults living in
non-metro areas are more likely to never get vaccinated similar to adults without internet
access, while adults with internet access are more likely to get vaccinated every year.
Perceptions and socioeconomic factors
Adults who perceive that the influenza vaccine is very effective are more likely to get
vaccinated every year, while adults who perceive that the influenza vaccine is not effective
are more likely to never get vaccinated. A higher proportion of adults are getting vaccinated
every year to protect themselves and others, and they are influenced by vaccine uptake
behavior within their social networks. Adults with health insurance are more likely to
get vaccinated every year, while adults without health insurance are more likely to never
get vaccinated. Adults without out-of-pocket payments, as well as those for whom the
cost of influenza vaccination is fully covered by health insurance, are more likely to get
vaccinated every year. Adults who do not get vaccinated every year are more likely to
never get vaccinated due to low perceptions of vaccine effectiveness and risk of influenza
infection, high perception of risky side effects, disliking shots, and ‘‘just not getting around
to do it’’.
Facilitators
Facilitators for adults getting vaccinated every year in comparison to only some years
include older age, perception of high vaccine effectiveness, higher income and no out-of-
pocket payments. Elderly adults are likely to get the influenza vaccine every year based
on their positive experience of influenza vaccination from past years, as well as act on the
influenza vaccine recommendation of their physicians during their clinical visits on health
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conditions that are not necessarily related to influenza (Lu et al., 2016). Adults with a
perception of high vaccine effectiveness are likely to get the influenza vaccination based on
their positive vaccine sentiment. Higher income and no out-of-pocket payments through
health insurance minimize the financial burden of the influenza vaccine cost as well as the
cost of taking time off from work and travel to get the vaccine (Jerant et al., 2013).
Adults are also influenced by vaccine uptake behavior within their social networks,
including a higher likelihood of adults getting vaccinated every year if others around them
are not vaccinated. This social influence can be partly explained by the Philipson model
(Geoffard & Philipson, 1997; Philipson, 2000) which posits that higher disease prevalence
leads to higher demand for public health interventions. An individual within a network of
unvaccinated people has an enhanced risk of infection for influenza, thereby nudging the
individual’s choice to protect themselves by getting vaccinated.
Barriers
Barriers for adults never getting vaccinated in comparison to only some years include lack of
health insurance, disliking of shots, perception of low vaccine effectiveness, low perception
of risk for influenza infection, and perception of risky side effects. Adults without health
insurance are less likely to seek preventive care including influenza vaccination (Jerant et
al., 2013). While the live attenuated influenza vaccine administered through a intranasal
sprayer may appeal to adults who dislike shots in comparison to the inactivated influenza
vaccine administered through an intramuscular injection, the Advisory Committee on
Immunization Practices does not recommend the use of live attenuated influenza vaccine
(Grohskopf et al., 2017).
Vaccine hesitancy and negative vaccine sentiment continues to contribute to suboptimal
vaccination coverage in the United States for influenza and other vaccine-preventable
diseases, posing significant risk of disease outbreaks (Kang, Culp & Abbas, 2017; Kang
et al., 2017). The perception of negative sentiment in vaccine effectiveness, risk for influenza
infection and risky side effects lends to vaccine hesitancy and reduces trust and confidence
in influenza vaccines. Vaccine hesitancy can be addressed by leveraging the commercial
and social marketing practices and principles of the four P’s, namely Product, Price, Place
and Promotion (Nowak et al., 2015). Specific to influenza vaccination, the product is the
influenza vaccine, recommended annual vaccination schedule of individuals sixmonths and
older, and the act of getting vaccinated. The price category refers to the cost, convenience,
ease of access, and perception of safety and efficacy of the influenza vaccine. The place
category refers to the location where the influenza vaccine is administered, such as doctors’
offices, clinics, and pharmacies. The promotion category refers to the influenza vaccine
messaging and communication through posters, brochures, public service advertisements
and websites, outreach through traditional news media and social media, spokespersons,
and interpersonal communication including patient-provider communication. Thereby,
addressing vaccine hesitancy and improving trust and confidence in vaccines by leveraging
these principles and practices in commercial and social marketing has appreciable value in
improving influenza vaccine acceptance (Larson et al., 2015; Larson et al., 2018; Nowak et
al., 2015).
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Limitations
Our survey was administered to a nationally representative sample of adults 18 years and
older in the United States; thereby, we are unable to extend our analysis to include children
below 18 years of age.
CONCLUSION
Health program strategies based on systems thinking focus on an ongoing, iterative learning
of systems understanding, analysis, and improvement (Swanson et al., 2012). Influenza
vaccination rates among adults in the United States are impacted by demographics,
perceptions, and socioeconomic factors. Through systematic understanding, analysis,
and identification of these influencing factors, this study provides evidence to improve
the design and implementation of current and future influenza vaccination programs
by leveraging the facilitators and addressing the barriers. Specifically, the public health
implications of this study are that the influenza vaccination rates among adults in the
United States can be improved towards the Healthy People 2020 target of 70% by increasing
awareness of the safety, efficacy and need for influenza vaccination, leveraging the practices
and principles of commercial and social marketing to improve vaccine trust, confidence
and acceptance, and lowering out-of-pocket payments and covering influenza vaccination
costs through health insurance.
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